1. Home
  2. ENSC vs GVH Comparison

ENSC vs GVH Comparison

Compare ENSC & GVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ensysce Biosciences Inc.

ENSC

Ensysce Biosciences Inc.

N/A

Current Price

$0.53

Market Cap

1.7M

Sector

Health Care

ML Signal

N/A

Logo Globavend Holdings Limited

GVH

Globavend Holdings Limited

N/A

Current Price

$1.22

Market Cap

2.7M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ENSC
GVH
Founded
2003
2016
Country
United States
Australia
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7M
2.7M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
ENSC
GVH
Price
$0.53
$1.22
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$80.00
AVG Volume (30 Days)
11.2M
2.9M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$102,768.97
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$0.74
Revenue Growth
N/A
N/A
52 Week Low
$0.31
$0.03
52 Week High
$4.90
$10.74

Technical Indicators

Market Signals
Indicator
ENSC
GVH
Relative Strength Index (RSI) 47.32 45.95
Support Level $0.31 $0.88
Resistance Level $0.73 $1.79
Average True Range (ATR) 0.08 0.13
MACD 0.04 0.04
Stochastic Oscillator 48.51 51.43

Price Performance

Historical Comparison
ENSC
GVH

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

About GVH Globavend Holdings Limited

Globavend Holdings Ltd is an e-commerce logistics provider, it provides integrated cross-border logistics services from Hong Kong to Australia and New Zealand, where it provides customers with a one-stop solution from parcel consolidation to air freight forwarding, customs clearance, on-carriage parcel transportation and delivery. It operates in logistics and freight forwarding industry, which involves the provision of services such as freight transport, freight forwarding, warehouse management, and distribution.

Share on Social Networks: